# Noxsano

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/noxsano

- Industry: Medical Devices & Equipment
- Headquarters: Columbus, US
- Website: www.noxsano.com
- Total disclosed funding: $0.2M
- Latest round: Seed (Aug 17, 2017)
- Investors on record: 1

## About

Noxsano Inc. specializes in advanced wound care solutions utilizing innovative nitric oxide technology to promote faster healing in veterinary medicine.Founded in 2016 in Columbus, US, Noxsano Inc. focuses on advanced wound care for veterinary professionals and animal care facilities. The company has undergone no significant pivots and has not been reported as part of a parent or subsidiary structure. The founders of Noxsano Inc. are Alan Willey and Stevan Samuel, with Willey serving as CEO. Noxsano raised USD 0.18 mn in Seed funding in August 2017, led by Rev1 Ventures, bringing their total amount raised to USD 0.18 mn.Noxsano specializes in advanced wound care solutions that leverage innovative nitric oxide technology to promote faster healing. The company offers two primary products: Restore Wound Pads and Restore Wound Gel. Restore Wound Pads are designed for application over various types of wounds where moisture retention is beneficial, while Restore Wound Gel is particularly effective for larger or more complex wounds that require direct application. Both products activate with water or saline, producing nitric oxide at the site of injury to enhance healing and reduce infection risks. Noxsano's products are primarily targeted at veterinary professionals and animal care facilities, serving a diverse clientele that includes veterinarians and animal hospitals across North America and Europe.Revenue generation at Noxsano is facilitated through direct sales of their wound care products to veterinary clinics, hospitals, and animal care providers. The company operates on a business-to-business (B2B) model, where transactions typically involve bulk orders from veterinary practices looking to stock their supplies. Pricing structures for the product offerings are established based on pack sizes, with specific configurations such as the five-pack options for both the Wound Pads and Wound Gel representing standard purchase units. With a focus on delivering effective wound care, Noxsano's flagship products have been well-received in the market, establishing a loyal customer base among veterinary professionals seeking reliable and efficient healing solutions for their patients.Noxsano plans to leverage its recent Seed funding of USD 0.18 mn raised in August 2017 to support the development of new products, including enhanced formulations of their existing wound care solutions. The company is also exploring opportunities to expand its market presence in Europe, targeting veterinary clinics and animal healthcare facilities, with an aim to enter this market by late 2024. With the intention of utilizing the funds for strategic marketing and product development, Noxsano aims to strengthen its position within the veterinary wound care sector.

## Funding rounds

- Seed, Aug 17, 2017, $0.2M — Rev1 Ventures

## Investors

- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Seed